Muraki Y, Kitamura M, Maeda Y, Kitahara T, Mori T, Ikeue H, Tsugita M, Tadano K, Takada K, Akamatsu T, Yamada T, Yamada T, Shiraishi T, Okuda M. Nationwide surveillance of antimicrobial consumption and resistance to Pseudomonas aeruginosa isolates at 203 Japanese hospitals in 2010. Infection. 2013;41:415–23.
CAS
PubMed
Article
Google Scholar
Polk RE, Fox C, Mahoney A, Letcavage J, MacDougall C. Measurement of adult antibacterial drug use in 130 US hospitals: comparison of defined daily dose and days of therapy. Clin Infect Dis. 2007;44:664–70.
CAS
PubMed
Article
Google Scholar
Cizman M; Slovenian Consumption Study Group. Nationwide hospital antibiotic consumption in Slovenia. J Antimicrob Chemother. 2011;66:2189–91.
CAS
PubMed
Article
Google Scholar
Kwint HM, van der Linden PD, Roukens MM, Natsch S; SWAB’s Working Group on Surveillance of Antimicrobial Use. Intensification of antibiotic use within acute care hospitals in the Netherlands. J Antimicrob Chemother. 2012;67:2283–8.
CAS
PubMed
Article
Google Scholar
Zarb P, Coignard B, Griskeviciene J, Muller A, Vankerckhoven V, Weist K, Goossens MM, Vaerenberg S, Hopkins S, Catry B, Monnet DL, Goossens H, Suetens C; National Contact Points for the ECDC pilot point prevalence survey; Hospital Contact Points for the ECDC pilot point prevalence survey. The European Centre for Disease Prevention and Control (ECDC) pilot point prevalence survey of healthcare-associated infections and antimicrobial use. Euro Surveill. 2012;17: pii: 20316.
Google Scholar